Blumhouse and Atomic Monster have a new corporate name — Blumhouse Atomic — and the Blumhouse Atomic new name, unveiled on Tuesday 3 November, simplifies the Blumhouse Atomic Monster identity the merged company has carried since the two horror studios joined forces in 2024. Jason Blum’s Blumhouse and James Wan’s Atomic Monster will continue as distinct production labels, each with its own creative team, under the new umbrella.
A $2.5 billion track record behind the rebrand
According to TheWrap and Bloody Disgusting, the combined company’s horror slate has generated more than $2.5 billion in worldwide box office against combined production budgets of less than $330 million since the merger. Recent hits cited include Curry Barker’s Obsession and Kane Parsons’ Backrooms, alongside Wan’s Conjuring franchise. Blum said in a statement: “When we merged our companies, we believed the whole would be greater than the sum of its parts, and that is exactly what has happened. Blumhouse Atomic is a natural evolution of what we’ve built together.”
Wan added, in a statement quoted by FemaleFirst and Bang Premier on November 4: “The future of horror comes from new voices, and Blumhouse Atomic gives us more ways to find them and support them for the long haul.” The rebrand does not fold the two labels together or replace either brand on individual films; it gives the parent company a shorter identity for deals, slates and industry positioning. Audiences will likely notice nothing at all on screen — the Blumhouse and Atomic Monster names remain where they belong, on the films themselves.
What comes next in 2027
Deadline’s slate reporting, summarised by Bloody Disgusting, lists the 2027 slate as including River, The Revenge of La Llorona, The Exorcist: Martyrs, Anything But Ghosts, Paranormal Activity, Molepeople, Blair Witch Project, Sleepover and Seasons, with a big-screen return of the Saw franchise also in development. The A.V. Club adds that Sleepover stars Parker Posey and that Anything But Ghosts is Barker’s buddy comedy. For horror fans, the name change is cosmetic; the slate is the substance — and it suggests Blumhouse Atomic intends to dominate horror in 2027 with both franchise returns and original titles.
